Literature DB >> 17568566

Increased response to ketamine following treatment at long intervals: implications for intermittent use.

Keith A Trujillo1, Juan J Zamora, Kathleen P Warmoth.   

Abstract

BACKGROUND: Ketamine has been used for many years as a dissociative anesthetic; however, there is evidence of increasing abuse, especially at dance clubs and raves. In addition, there is increasing interest in the use of subanesthetic doses of ketamine for the treatment of pain and depression, as well as for clinical research on schizophrenia. Despite growing use, relatively little is known about the consequences of repeated administration of low doses of ketamine.
METHODS: To determine the changes in response to repeated administration, ketamine (20 mg/kg or 50 mg/kg intraperitoneal [IP]) was administered once weekly to laboratory rats and the locomotor response was assessed following each injection.
RESULTS: Repeated administration of ketamine led to an escalation in the stimulant effects of the drug, characteristic of behavioral sensitization. The development of sensitization was greater when ketamine was repeatedly administered in the presence of distinct environmental cues.
CONCLUSIONS: Intermittent administration of ketamine at weekly intervals leads to the development of locomotor sensitization. These results suggest caution in the repeated use of ketamine for recreational or clinical purposes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568566     DOI: 10.1016/j.biopsych.2007.02.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  25 in total

Review 1.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

Authors:  Mark J Niciu; Ioline D Henter; David A Luckenbaugh; Carlos A Zarate; Dennis S Charney
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

2.  Lack of persistent effects of ketamine in rodent models of depression.

Authors:  Piotr Popik; Tomasz Kos; Magdalena Sowa-Kućma; Gabriel Nowak
Journal:  Psychopharmacology (Berl)       Date:  2008-05-07       Impact factor: 4.530

3.  Enduring effects of adolescent ketamine exposure on cocaine- and sucrose-induced reward in male and female C57BL/6 mice.

Authors:  Israel Garcia-Carachure; Francisco J Flores-Ramirez; Samuel A Castillo; Anapaula Themann; Miguel A Arenivar; Joshua Preciado-Piña; Arturo R Zavala; Mary Kay Lobo; Sergio D Iñiguez
Journal:  Neuropsychopharmacology       Date:  2020-03-12       Impact factor: 7.853

4.  Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol.

Authors:  Y Li; J Shi; B F Yang; L Liu; C L Han; W M Li; D L Dong; Z W Pan; G Z Liu; J Q Geng; L Sheng; X Y Tan; D H Sun; Z H Gong; Y T Gong
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

5.  Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.

Authors:  Angelica Rocha; Nigel Hart; Keith A Trujillo
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

6.  Long-lasting effects of repeated ketamine administration in adult and adolescent rats.

Authors:  M L Shawn Bates; Keith A Trujillo
Journal:  Behav Brain Res       Date:  2019-04-26       Impact factor: 3.332

7.  Ketamine effect on HMGB1 and TLR4 expression in rats with acute lung injury.

Authors:  Ming-Zhe Qin; Qiu-Han Gu; Jun Tao; Xiao-Yang Song; Guo-Sheng Gan; Zhong-Bin Luo; Bi-Xi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

8.  Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.

Authors:  G F Brum; H Z Rosa; D R Rossato; J L O Rosa; V G Metz; L H Milanesi; M E Burger
Journal:  Neurotox Res       Date:  2020-05-26       Impact factor: 3.911

9.  Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in rats.

Authors:  Marco Venniro; Anna Mutti; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2015-09-21       Impact factor: 4.530

Review 10.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.